A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF GDC-8264 IN PREVENTING CARDIAC SURGERY-ASSOCIATED ACUTE KIDNEY INJURY AND MAJOR ADVERSE KIDNEY EVENTS
Clinical Trial Grant
Administered By
Anesthesiology, General, Vascular, High Risk Transplant & Critical Care
Awarded By
Genentech, Inc.
Start Date
October 21, 2024
End Date
October 31, 2025
Administered By
Anesthesiology, General, Vascular, High Risk Transplant & Critical Care
Awarded By
Genentech, Inc.
Start Date
October 21, 2024
End Date
October 31, 2025